Eli Lilly Patents – Key Insights and Stats

Eli Lilly has a total of 3917 patents globally, out of which 1553 have been granted. Of these 3917 patents, more than 27% patents are active. United States of America is where Eli Lilly has filed the maximum number of patents, followed by Europe and Japan, it has generated an annual revenue of $28.32 billion in the year 2021. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Eli Lilly.

Eli Lilly was founded in the year 1876 by Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. Company is an American pharmaceutical firm with offices in 18 countries and headquarters in Indianapolis, Indiana. As of February 2022, Eli Lilly has a market cap of $ 227.96 Billion.

Do read about some of the most popular patents of Eli Lilly which have been covered by us in this article and also you can find Eli Lilly’ patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Eli Lilly’ patent portfolio.

How many patents does the founder and the CEO of Eli Lilly have?

The founder, Eli Lilly, has 102 patents. The CEO, David A. Ricks, has 0 patents.

How many patents does Eli Lilly have?

Eli Lilly has a total of 3917 patents globally. These patents belong to 644 unique patent families. Out of 3917 patents, 1065 patents are active.

How many Eli Lilly patents are Alive/Dead?

Worldwide Patents

Eli Lilly Worldwide Legal Trends

Patent Families

Eli Lilly patent portfolio

How Many Patents did Eli Lilly File Every Year?

Eli Lilly Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEli Lilly Applications FiledEli Lilly Patents Granted
2011135102
201257106
20134594
20149895
201511079
201617960
201715862
201813232
20195936
20205156
2021179
20225

How Many Patents did Eli Lilly File in Different Countries?

Eli Lilly Worldwide Filing in Top 10 Countries

Countries in which Eli Lilly Filed Patents

CountryPatents
United States Of America466
Europe360
Japan290
Australia241
Canada195
China150
Germany137
Hong Kong (S.A.R.)113
Israel106
Korea (South)103
Mexico95
Spain94
Brazil89
India76
Austria70
Denmark62
Singapore58
Portugal58
Poland55
New Zealand47
South Africa40
Norway40
Taiwan39
Slovenia36
Hungary31
Chile30
Philippines28
Argentina28
Cyprus26
Malaysia25
Indonesia23
Croatia21
Czech Republic20
Peru19
Russia19
Slovakia18
Tunisia18
Ukraine18
Viet Nam16
Morocco16
Costa Rica15
Colombia13
Serbia12
Ecuador12
Jordan11
Lithuania9
Dominican Republic9
United Kingdom8
Uruguay8
Luxembourg8
Macao8
El Salvador7
Finland6
Montenegro6
Turkey6
Estonia6
Georgia5
Greece5
Iceland5
Netherlands4
Bulgaria4
Panama3
Kazakhstan3
Ireland2
Botswana1
Egypt1
Guatemala1
Cuba1
Latvia1
Mongolia1
Gulf Cooperation Council1
Honduras1
Brunei1
Nicaragua1
Romania1
African Intellectual Property Organization1
Saudi Arabia1

Where are Research Centers of Eli Lilly Patents Located?

Eli Lilly R&D Centres

10 Best Eli Lilly Patents

WO2005070963A1 is the most popular patent in the Eli Lilly portfolio. It has received 736 citations so far from companies like Xencor, Applied Molecular Evolution, and Immunogen.

Below is the list of 10 most cited patents of Eli Lilly:

Publication NumberCitation Count
WO2005070963A1736
US20040002587A1587
WO2005113556A1568
US20040102804A1538
WO2001027160A1394
US6241740B1364
US6800620B2324
US6527786B1320
US7288096B2318
US20020103345A1307

Which Companies are using Eli Lilly Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Eli Lilly patent portfolio are Medtronic, Gilead Calistoga, and ReNeuron.

List of the top forward citing Companies –

CompanyNumber of Patents
Medtronic20
Gilead Calistoga15
ReNeuron10
Athena GTX10
Ablynx9
Amgen8
National Institutes of Health8
The University Of Chicago7
Pf Consumer Healthcare 1 LLC7
IBC Pharmaceuticals7

Count of 102 and 103 Type Rejections based on Eli Lilly Patents

Top Eli Lilly Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20040102804A112
US20040002587A19
US7288096B28
US6610031B16
US20060106038A15
US20040242851A15
US20100172836A14
US7115716B23
US7705000B23
US7361763B23
US20080234291A13
US8071581B23
US20090306348A13
US20060009465A13
US8562949B23

What Percentage of Eli Lilly US Patent Applications were Granted?

Eli Lilly (Excluding its subsidiaries) has filed 3274 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2413 have been granted leading to a grant rate of 85.11%.

Below are the key stats of Eli Lilly patent prosecution at the USPTO.

Lilly’s major accomplishments include becoming the first business to mass-produce Jonas Salk’s polio vaccine and insulin. Prozac, Dolophine, Cymbalta , and Zyprexa are all produced by Lilly, which is presently the largest maker of psychiatric drugs.

In 2020, the need for digital health adoption accelerated, owing in part to the COVID-19 pandemic. HCPs are urging persons with chronic illnesses to use digital services such as telehealth to continue their care when social distance and stay-at-home orders are in place, for example.

In an early-stage feasibility study, Lilly collaborated with Apple, Inc. and Evidation Health to show that an iPhone, Apple Watch, iPad, and the Beddit sleep monitoring device, in combination with digital apps, can distinguish people with mild cognitive impairment (MCI) and mild Alzheimer’s disease dementia.

Migraine pain can be so severe that in a survey recently released by Eli Lilly and Company, respondents in a survey performed by Nielsen for Eli Lilly and Company rated the worst migraine pain higher than the pain associated with kidney stones and fractured bones.

There were no migraine-specific preventive medications available until recently. Existing treatments were either difficult to tolerate or ineffective for many people. With the introduction of CGRP inhibitors, this is changing. This novel medication prevents the absorption of calcitonin gene-related peptide, or CGRP, a protein linked to migraines caused by inflammation.

Which Law Firms Filed Most US Patents for Eli Lilly?

Law FirmTotal ApplicationSuccess Rate
Eli Lilly And Company328595.77%
Elanco Us Inc.8194.81%
Amylin Pharmaceuticals, Inc.11979.97%
Goldman Sachs Bank Usa, As Collateral Agent5297.92%
Sall, Daniel Jon51100.00%
Audia, James E.5097.62%
Astrazeneca Pharmaceuticals Lp4182.93%
Sawyer, Jason Scott4190.63%
Wiley, Michael Robert4197.44%
Brady, Lois I.3942.42%

EXCLUSIVE INSIGHTS COMING SOON!

What are Eli Lilly’s key innovation segments?

What Technologies are Covered by Eli Lilly?

The chart below distributes patents filed by Eli Lilly in different countries on the basis of the technology protected in patents. It also represents the markets where Eli Lilly thinks it’s important to protect particular technology inventions.

R&D Focus: How Eli Lilly search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Eli Lilly?

Updated on May 4, 2022

Was this article helpful?

Leave a Comment